Gladys, an AI Home Care platform, has secured £1.5 million in seed funding to enhance its services across the UK, aiming to transform the home care industry by connecting families with local caregivers.

Information on the Target

Gladys is an innovative AI Home Care technology platform aimed at addressing the challenges within the UK’s home care system. By connecting care seekers with the best local carers, Gladys facilitates access to high-quality care while eliminating intermediaries. This approach not only enhances the overall experience for families seeking assistance but also empowers local caregivers who often face underappreciation and underpayment.

Co-founded by former barrister George Robinson and seasoned HealthTech entrepreneur Alex Sorisi, Gladys has already made significant strides by delivering care over an expansive 20,000 km area and supporting tens of thousands of hours of independent living. The platform's AI-powered solutions not only alleviate the burden of finding suitable care but also reward caregivers with up to 65% more than traditional agency rates, positioning Gladys as a disruptive force in the home care landscape.

Industry Overview in the UK

The UK home care sector is currently facing a myriad of challenges, including rising costs and demand pressures. With an aging population and an increased emphasis on independent living, families are often overwhelmed when

View Source

Similar Deals

The Yield Lab NoBACZ Healthcare

2025

Seed Stage Bio Medical Devices United Kingdom
Sofinnova Partners Forth Therapeutics

2025

Seed Stage Bio Therapeutic Drugs United Kingdom
Lifted Ventures Anya

2025

Seed Stage Healthcare Facilities & Services (NEC) United Kingdom
redalpine, IQ Capital Partners, Seedcamp DaltonTx

2025

Seed Stage Proprietary & Advanced Pharmaceuticals United Kingdom
Access EIS MindSpire

2025

Seed Stage Alternative Medicine Facilities United Kingdom
Calculus Capital Laverock Therapeutics

2025

Seed Stage Bio Therapeutic Drugs United Kingdom

Cornerstone

invested in

Gladys

in 2025

in a Seed Stage deal

Disclosed details

Transaction Size: $2M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert